Yu JH - Search Results

1

Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment.

Yu JH, Kim JK, Lee KS, Lee JI. Yu JH, et al. J Clin Gastroenterol. 2018 Jul;52(6):557-562. doi: 10.1097/MCG.0000000000000923. J Clin Gastroenterol. 2018. PMID: 28863014

2

Clinical characteristics of acute hepatitis A complicated by acute kidney injury.

Yu JH, Kim JK, Park JY, Paik YH, Kim DY, Ahn SH, Han KH, Chon CY, Lee KS. Yu JH, et al. Scand J Infect Dis. 2012 Feb;44(2):144-8. doi: 10.3109/00365548.2011.592145. Epub 2011 Jul 8. Scand J Infect Dis. 2012. PMID: 21736511

3

Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis.

Yu JH, Song SJ, Kim A, Choi Y, Seok JW, Kim HJ, Lee YJ, Lee KS, Kim JW. Yu JH, et al. Sci Rep. 2016 Jul 11;6:29352. doi: 10.1038/srep29352. Sci Rep. 2016. PMID: 27404390 Free PMC article.

4

Current role of transient elastography in the management of chronic hepatitis B patients.

Yu JH, Lee JI. Yu JH, et al. Ultrasonography. 2017 Apr;36(2):86-94. doi: 10.14366/usg.16023. Epub 2016 Oct 26. Ultrasonography. 2017. PMID: 27956732 Free PMC article. Review.

5

Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.

Yu JH, Kim JM, Kim JK, Choi SJ, Lee KS, Lee JW, Chang HY, Lee JI. Yu JH, et al. Oncotarget. 2017 Jun 13;8(24):39534-39546. doi: 10.18632/oncotarget.17134. Oncotarget. 2017. PMID: 28465473 Free PMC article.

6

Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C.

Yu JH, Lee JI, Lee KS, Kim JK. Yu JH, et al. Virol J. 2017 Aug 24;14(1):164. doi: 10.1186/s12985-017-0826-1. Virol J. 2017. PMID: 28836992 Free PMC article.

7

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

Yu JH, Lee JW. Yu JH, et al. Clin Mol Hepatol. 2019 Sep;25(3):280-282. doi: 10.3350/cmh.2018.0104. Epub 2019 Jan 21. Clin Mol Hepatol. 2019. PMID: 30661335 Free PMC article. No abstract available.

8

Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.

Lee JI, Yu JH, Anh SG, Lee HW, Jeong J, Lee KS. Lee JI, et al. Among authors: yu jh. Oncologist. 2019 Aug;24(8):e653-e661. doi: 10.1634/theoncologist.2018-0370. Epub 2019 Jan 24. Oncologist. 2019. PMID: 30679317 Free PMC article.

9

Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir.

Yu JH, Suh YJ, Jin YJ, Heo NY, Jang JW, You CR, An HY, Lee JW. Yu JH, et al. Eur J Gastroenterol Hepatol. 2019 Jul;31(7):865-872. doi: 10.1097/MEG.0000000000001357. Eur J Gastroenterol Hepatol. 2019. PMID: 30694912

10

Effective therapeutic options for elderly patients with hepatocellular carcinoma: A nationwide cohort study.

Shin J, Yu JH, Jin YJ, Suh YJ, Kim DH, Byun S, Lee JW. Shin J, et al. Among authors: yu jh. Medicine (Baltimore). 2019 Jul;98(30):e16150. doi: 10.1097/MD.0000000000016150. Medicine (Baltimore). 2019. PMID: 31348228 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,567 results

Search Page

Filters